Is it better to remove pharmaceuticals in decentralized or conventional wastewater treatment plants? A life cycle assessment comparison

Science of the Total Environment

Volumn 438, Issue , 2012, Pages 533-540

  Igos, Elorri ^a   Benetto, Enrico ^a   Venditti, Silvia ^a   Kohler, Christian ^a   Cornelissen, Alex ^a   Moeller, Ruth ^a   Biwer, Arno ^a  

^a LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY   (Luxembourg)

Author keywords

Activated carbon; Life Cycle Assessment; Ozonation; Pharmaceuticals; Toxicity; UV

Indexed keywords

AS LOW AS REASONABLY ACHIEVABLE; ASSESSMENT MODELS; CONVENTIONAL TREATMENTS; EUROPEAN PROJECT; FULL SCALE; HOLISTIC APPROACH; LIFE CYCLE ASSESSMENT (LCA); POINT SOURCES; POST TREATMENT; TREATMENT PLANTS; USING LIFE; UV; WASTEWATER TREATMENT PLANTS;

ACTIVATED CARBON; DRUG PRODUCTS; LIFE CYCLE; OZONE; OZONIZATION; PELLETIZING; PILOT PLANTS; SEWAGE PUMPING PLANTS; WATER TREATMENT PLANTS;

TOXICITY;

ACTIVATED CARBON; ATENOLOL; CARBAMAZEPINE; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DICLOFENAC; DRUG; HEAVY METAL; LIDOCAINE; NITROGEN; PARACETAMOL; PHOSPHORUS; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACTIVATED CARBON; COMPARATIVE STUDY; DRUG; ENVIRONMENTAL IMPACT ASSESSMENT; LIFE CYCLE ANALYSIS; TOXICITY; ULTRAVIOLET RADIATION; WASTEWATER;

ARTICLE; CENTRALIZATION; DECENTRALIZATION; ECOTOXICITY; ENVIRONMENTAL IMPACT; ENVIRONMENTAL RELEASE; HOSPITAL; LIFE CYCLE ASSESSMENT; OZONATION; PRIORITY JOURNAL; TOXICITY TESTING; ULTRAVIOLET RADIATION; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WATER CONTAMINATION;

ENVIRONMENT; HOSPITALS; MODELS, THEORETICAL; PHARMACEUTICAL PREPARATIONS; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION;

EID: 84868024324     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.08.096     Document Type: Article

References (43)

1. Abegglen C, Escher B, Hollender J, Koepke S, Ort C, Peter A, Siegrist H, von Gunten U, Zimmemann S, Koch M, Niderhauser P, Schärer M, Braun C, Gälli R, Junghans M, Brocker S, Moser R, Rensch D. Ozonung von gereinigtem Abwasser Schlussbericht Pilotversuch Regensdorf. Report Eawag, AWEL ZH, BAFU, BMG Engineering, Hunziker Betachen AG, Dübendorf; 2009.
2. Ahnert M., Kuehn V., Krebs P. Identification of overall degradation in sewer systems from long-term measurements and consequences for WWTP simulations. Water Sci Technol 2005, 52(3):153-161.
3. ChemIDplus Advanced database (Last accessed 2012/06/22). http://chem.sis.nlm.nih.gov/chemidplus/chemidheavy.jsp.
4. Chfetz B., Mualem T., Ben-Ari J. Sorption and mobility of pharmaceutical compounds in soil irrigated with reclaimed wastewater. Chemosphere 2008, 73(8):1335-1343.
5. Clara M., Strenn B., Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during ground water infiltration. Water Res 2004, 38(4):947-954.
6. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 2005, 39(19):4797-4807.
7. Council Directive of 21 May 1991 Concerning urban waste water treatment (91/271/EEC). Off J Eur Communities 1991, L 135:40.
8. Carcinogenic potency database (CPDB) Website (Last accessed, 2012/06/22). http://potency.berkeley.edu/chemicalsummary.html.
9. Doka G. Life cycle inventories of waste treatment services. Ecoinvent report No. 13 2007, Swiss Centre for Life Cycle Inventories, Dübendorf.
10. Ecoinvent centre Swiss Centre for Life Cycle Inventories Website (Last accessed 2012/06/22). http://www.ecoinvent.ch/.
11. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 2011, 45:75-92.
12. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006, 76:122-159.
13. Geisler G., Hellweg S., Hungerbühler K. Uncertainty analysis in Life Cycle Assessment (LCA): case study on plant protection products and implications for decision making. Int J LCA 2005, 10(3):192.1-192.3.
14. Gibson R., Duràm-Alvarez J.C., Estrada K.L., Chàvez A., Jiménez Cisneros B. Accumulation and leaching potential of some pharmaceuticals and potential endocrine disruptors in soils irrigated with wastewater in the Tula Valley, Mexico. Chemosphere 2010, 81(11):1437-1445.
15. Giger W., Alder A.C., Golet E.M., Kohler H.P.E., McArdell C., Molnar E., et al. Occurrence and fate of antibiotics as trace contaminants in wasters, sewage sludges, and surface waters. Chimia 2003, 57:485-491.
16. Göbel A., Thomsen A., Mcardell C., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ Sci Technol 2005, 39:3981-3989.
17. Goedkoop M., Heijungs R., Huijbregts M.A.J., An Schryver D., Struijs J., Van Zelm R. ReCiPe 2008 A Life Cycle Impact Assessment Method which Comprises Harmonised Category Indicators at the Midpoint and the Endpoint Level 2009, Report I, Characterisation, Report VROM, Netherlands. First Edition.
18. Gros M., Petrovic M., Ginebreda A., Barcelo D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 2010, 36:15-26.
19. Hauschild M., Wenzel H. Environmental Assessment of Products 1998, vol. 2. scientific backgrounds, Chapman and Hall, London.
20. Hospido A., Carballa M., Moreira M., Omil F., Lema J.M., Feijoo G. Environmental assessment of anaerobically digested sludge reuse in agriculture: potential impacts of emerging micropollutants. Water Res 2010, 44:3225-3233.
21. Hvitved-Jacobsen T., Vollertsen J., Matos J. The sewer as a bioreactor - a dry weather approach. Water Sci Technol 2002, 45(3):51-60.
22. ISO-International Organisation For Standardisation Environmental Management - Life Cycle Assessment ISO 14040 Principles and Framework ISO 14044 Requirements and Guidelines 2006, EN ISO 14044. ISO, Geneva.
23. Jolibois B., Guerbet M. Hospital wastewater genotoxicity. Ann Occup Hyg 2006, 50(2):189-196.
24. Joss A., Keller E., Alder A., Göbel A., McArdell C., Terners T., et al. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 2005, 39(14):3139-3152.
25. Kinney C.A., Furlong E.T., Werner S.L., Cahill J.D. Presence and distribution of wastewater-derived pharmaceuticals in soil irrigated with reclaimed water. Environ Chem 2009, 25(2):317-326.
26. Kratz W. Ecotoxicological risk of human pharmaceuticals in Brandeburg surface waters ?. Stand Threshold Impact Assess 2008, 30:379-389.
27. Larsen H.F., Hauschild M. Evaluation of ecotoxicity effect indicators for use in LCIA. Int J LCA 2007, 12(1):24-33.
28. Larsen H.F., Hansen P.A., Boyer-Souchet F. NEPTUNE: Deliverable 4.3 - decision support guideline based on LCA and costs/efficiency assessment. Report Neptune FP6 project 2010.
29. Lassaux S., Renzoni R., Germanin A. Life cycle assessment of water: from the pumping station to the wastewater treatment plant. Int J LCA 2007, 12(2):118-126.
30. Laurent A., Olsen S.I., Hauschild M.Z. Normalization in EDIP97 and EDIP2003: updated European inventory for 2004 and guidance towards a consistent use in practice. Int J LCA 2011, 16:401-409.
31. McArdell C.S., Kovalova L., Siegrist H. Input and Elimination of Pharmaceuticals and Disinfectants from Hospital Wastewater 2011, Final report, Report Eawag, Dübendorf.
32. Miège C., Choubert J.M., Ribeiro L., Eusèbe M., Coquery M. Fate of pharmaceuticals and personal care products in wastewater treatment plants - conception of a database and first results. Environ Pollut 2009, 157:1721-1726.
33. Mulder M., Kujawa-Roeleveld K., Schuman E. Evaluation of PILLS/SLIK Demonstration Installation for Removal of Pharmaceutical Compounds from Hospital Wastewater 2012, Final report, Report Mirabella Mulder, RIVM, LeAF, Netherlands.
34. Muñoz I., Gómez M.J., Molina-Díaz A., Huijbregts M.-A.-J., Fernández-Alba A.-R., García-Calvo E. Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment. Chemosphere 2008, 74:37-44.
35. Potting J., Hauschild M. Background for Spatial Differentiation in LCA Impact Assessment - The EDIP2003 Methodology 2005, Danish Ministry of the Environment.
36. Rosenbaum R.K., Bachmann T.M., Gold L.S., Huijbregts M.A.J., Jolliet O., Juraske R., et al. USEtox-the UNEP-SETAC toxicity model: recommended characterization factors for human toxicity and freshwater ecotoxicity in life cycle impact assessment. Int J LCA 2008, 13:532-546.
37. Sleeswijk A.W., van Oers L.F.C.M., Guinée J.B., Struijs J., Huijbregts M.A.J. Normalisation in product life cycle assessment: an LCA of the global and European economic systems in the year 2000. Sci Total Environ 2008, 390:227-240.
38. Ternes T.A., Joss A. Human pharmaceuticals, hormones and fragrances: the challenge of micropollutants in urban water management 2006, IWA Publishing, London.
39. Ternes T.A., Hermann N., Bonerz M., Knacker T., Siegrist H., Joss A. A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. Water Res 2004, 38(19):4075-4084.
40. Umberto® Version 5.6.1.5792.Copyright 1994-2011 ifu Hamburg GmbH, ifeu - Institut für Energie- une Umweltforschung Heidelberg GmbH (Last accessed 2012/06/22). http://www.umberto.de/en/.
41. USEPA Website. Estimation Programs Interface EPI Suite (Last accessed 2012/06/22). http://www.epa.gov/opptintr/exposure/pubs/episuite.htm.
42. Vieno N., Tuhkanen T., Kronberg L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 2007, 14(5):1001-1012.
43. Wikipharma database (Last accessed 2012/06/22). http://www.wikipharma.org/api_data.asp.